Germany – Diagnostic systems – Framework agreement for reagent leasing for analysis by rapid PCR
The subject of the procurement is the conclusion of a framework agreement for reagent leasing for rapid PCR analysis for a respiratory 4-target panel. The service includes the provision of the reagents required for the analysis, quality controls, calibrators, consumables, small materials and other m
Opportunity description
The subject of the procurement is the conclusion of a framework agreement for reagent leasing for rapid PCR analysis for a respiratory 4-target panel. The service includes the provision of the reagents, quality controls, calibrators, consumables, small materials and other materials required for the analysis, as well as the provision, use and operation of the analytical devices required for this purpose, including software, interface/connection services, maintenance, repair, updates, support and other services. The respiratory 4-target panel includes the analysis of the respiratory viruses Influenza A, Influenza B, respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus (SARS-CoV/SARS-CoV-2). Remuneration is based on a uniform price per billable result. The subject of the procurement is the conclusion of a framework agreement for reagent leasing for rapid PCR analysis for a respiratory 4-target panel. The service includes the provision of the reagents, quality controls, calibrators, consumables, small materials and other materials required for the analysis, as well as the provision, use and operation of the analytical devices required for this purpose, including software, interface/connection services, maintenance, repair, updates, support and other services. The respiratory 4-target panel includes the analysis of the respiratory viruses Influenza A, Influenza B, respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus (SARS-CoV/SARS-CoV-2). The objective of the procurement is to ensure the economical, demand-oriented and reliable provision of rapid PCR analysis in the routine operations of LB and LBS. Remuneration is based on a uniform price per billable result. Separate result prices based on location, company, device or quantity are not envisaged. A maximum purchase limit of EUR 8,288,000.00 net is set for the framework agreement at issue here. Procedure: open. Estimated value: 4,144,000 EUR. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.